Tamibarotene and its Impurities

Tamibarotene is a new synthetic retinoid drug recently approved for relapsed or refractory acute promyelocytic leukemia in Japan.Reference standards of Tamibarotene API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.